Skip to main content
Erschienen in: Diabetologia 2/2010

01.02.2010 | Article

Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia

verfasst von: R. Retnakaran, Y. Qi, P. W. Connelly, M. Sermer, A. J. Hanley, B. Zinman

Erschienen in: Diabetologia | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The postpartum phase following gestational diabetes (GDM) is characterised by subtle metabolic defects, including the beta cell dysfunction that is believed to mediate the increased future risk of type 2 diabetes in this patient population. Low circulating levels of adiponectin and increased leptin and C-reactive protein (CRP) have recently emerged as novel diabetic risk factors, although their relevance to GDM and subsequent diabetes has not been characterised. Thus, we sought to determine whether adiponectin, leptin and CRP levels during pregnancy relate to the postpartum metabolic defects linking GDM with type 2 diabetes.

Methods

Metabolic characterisation, including oral glucose tolerance testing, was undertaken in 487 women during pregnancy and at 3 months postpartum. Based on the antepartum OGTT, there were 137 women with GDM, 91 with gestational impaired glucose tolerance and 259 with normal glucose tolerance.

Results

Adiponectin levels were lowest (p < 0.0001) and CRP levels highest (p = 0.0008) in women with GDM. Leptin did not differ between the glucose tolerance groups (p = 0.4483). Adiponectin (r = 0.41, p < 0.0001), leptin (r = −0.36, p < 0.0001) and CRP (r = −0.30, p < 0.0001) during pregnancy were all associated with postpartum insulin sensitivity (determined using the insulin sensitivity index of Matsuda and DeFronzo [ISOGTT]). Intriguingly, adiponectin levels were also related to postpartum beta cell function (insulinogenic index/HOMA of insulin resistance; r = 0.16, p = 0.0009). Indeed, on multiple linear regression analyses, adiponectin levels during pregnancy independently predicted both postpartum insulin sensitivity (t = 3.97, p < 0.0001) and beta cell function (t = 2.37, p = 0.0181), even after adjustment for GDM. Furthermore, adiponectin emerged as a significant negative independent determinant of postpartum fasting glucose (t = −3.01, p = 0.0027).

Conclusions/interpretation

Hypoadiponectinaemia during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia, and hence may be relevant to the pathophysiology relating GDM with type 2 diabetes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Buchanan TA, Xiang AH (2005) Gestational diabetes mellitus. J Clin Invest 115:485–491PubMed Buchanan TA, Xiang AH (2005) Gestational diabetes mellitus. J Clin Invest 115:485–491PubMed
2.
Zurück zum Zitat Feig DS, Zinman B, Wang X, Hux JE (2008) Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 179:229–234PubMed Feig DS, Zinman B, Wang X, Hux JE (2008) Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ 179:229–234PubMed
3.
Zurück zum Zitat Buchanan TA (2001) Pancreatic β-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 86:989–993CrossRefPubMed Buchanan TA (2001) Pancreatic β-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab 86:989–993CrossRefPubMed
4.
Zurück zum Zitat Schaefer-Graf UM, Buchanan TA, Xiang AH, Peters RK, Kjos SL (2002) Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol 186:751–756CrossRefPubMed Schaefer-Graf UM, Buchanan TA, Xiang AH, Peters RK, Kjos SL (2002) Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol 186:751–756CrossRefPubMed
5.
Zurück zum Zitat Sinha B, Brydon P, Taylor RS et al (2003) Maternal ante-natal parameters as predictors of persistent postnatal glucose intolerance: a comparative study between Afro-Caribbeans, Asians and Caucasians. Diabet Med 20:382–386CrossRefPubMed Sinha B, Brydon P, Taylor RS et al (2003) Maternal ante-natal parameters as predictors of persistent postnatal glucose intolerance: a comparative study between Afro-Caribbeans, Asians and Caucasians. Diabet Med 20:382–386CrossRefPubMed
6.
Zurück zum Zitat Albareda M, Caballero A, Badell G et al (2003) Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 26:1199–1205CrossRefPubMed Albareda M, Caballero A, Badell G et al (2003) Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 26:1199–1205CrossRefPubMed
7.
Zurück zum Zitat Pickup JC, Crook MA (1998) Is type 2 DM a disease of the innate immune system? Diabetologia 41:1241–1248CrossRefPubMed Pickup JC, Crook MA (1998) Is type 2 DM a disease of the innate immune system? Diabetologia 41:1241–1248CrossRefPubMed
8.
Zurück zum Zitat Rasouli N, Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93:S64–S73CrossRefPubMed Rasouli N, Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93:S64–S73CrossRefPubMed
9.
Zurück zum Zitat Pradham AD, Manson JE, Rifai N, Buring J, Ridker PM (2001) C-reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus. JAMA 286:327–334CrossRef Pradham AD, Manson JE, Rifai N, Buring J, Ridker PM (2001) C-reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus. JAMA 286:327–334CrossRef
10.
Zurück zum Zitat Welsh P, Murray HM, Buckley BM et al (2009) Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. Diabetes Care 32:308–310CrossRefPubMed Welsh P, Murray HM, Buckley BM et al (2009) Leptin predicts diabetes but not cardiovascular disease: results from a large prospective study in an elderly population. Diabetes Care 32:308–310CrossRefPubMed
11.
Zurück zum Zitat Li S, Shin HJ, Ding EL, van Dam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302:179–188CrossRefPubMed Li S, Shin HJ, Ding EL, van Dam RM (2009) Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302:179–188CrossRefPubMed
12.
Zurück zum Zitat Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B (2008) Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care 31:2026–2031CrossRefPubMed Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B (2008) Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care 31:2026–2031CrossRefPubMed
13.
Zurück zum Zitat Retnakaran R, Qi Y, Sermer M, Connelly PW, Zinman B, Hanley AJ (2008) Isolated hyperglycemia at 1-hour on oral glucose tolerance test in pregnancy resembles gestational diabetes in predicting postpartum metabolic dysfunction. Diabetes Care 31:1275–1281CrossRefPubMed Retnakaran R, Qi Y, Sermer M, Connelly PW, Zinman B, Hanley AJ (2008) Isolated hyperglycemia at 1-hour on oral glucose tolerance test in pregnancy resembles gestational diabetes in predicting postpartum metabolic dysfunction. Diabetes Care 31:1275–1281CrossRefPubMed
14.
Zurück zum Zitat Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B (2009) The antepartum glucose values that predict neonatal macrosomia differ from those that predict postpartum prediabetes or diabetes: implications for the diagnostic criteria for gestational diabetes. J Clin Endocrinol Metab 94:840–845CrossRefPubMed Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B (2009) The antepartum glucose values that predict neonatal macrosomia differ from those that predict postpartum prediabetes or diabetes: implications for the diagnostic criteria for gestational diabetes. J Clin Endocrinol Metab 94:840–845CrossRefPubMed
15.
Zurück zum Zitat National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039–1057 National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039–1057
16.
Zurück zum Zitat Matsuda M, DeFronzo R (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRefPubMed Matsuda M, DeFronzo R (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRefPubMed
17.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419CrossRefPubMed
18.
Zurück zum Zitat Wareham NJ, Phillips DI, Byrne CD, Hales CN (1995) The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 12:931CrossRefPubMed Wareham NJ, Phillips DI, Byrne CD, Hales CN (1995) The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 12:931CrossRefPubMed
19.
Zurück zum Zitat Kahn SE (2003) The relative contributions of insulin resistance and beta cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3–19CrossRefPubMed Kahn SE (2003) The relative contributions of insulin resistance and beta cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3–19CrossRefPubMed
20.
Zurück zum Zitat Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B (2004) Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 27:799–800CrossRefPubMed Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B (2004) Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 27:799–800CrossRefPubMed
21.
Zurück zum Zitat Retnakaran R, Connelly PW, Maguire G, Sermer M, Zinman B, Hanley AJ (2007) Decreased high molecular weight adiponectin in gestational diabetes: implications for the pathophysiology of type 2 diabetes. Diabet Med 24:245–252CrossRefPubMed Retnakaran R, Connelly PW, Maguire G, Sermer M, Zinman B, Hanley AJ (2007) Decreased high molecular weight adiponectin in gestational diabetes: implications for the pathophysiology of type 2 diabetes. Diabet Med 24:245–252CrossRefPubMed
22.
Zurück zum Zitat Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R (2003) First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 26:819–824CrossRefPubMed Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R (2003) First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 26:819–824CrossRefPubMed
23.
Zurück zum Zitat Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA (2004) Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 89:2306–2311CrossRefPubMed Williams MA, Qiu C, Muy-Rivera M, Vadachkoria S, Song T, Luthy DA (2004) Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 89:2306–2311CrossRefPubMed
24.
Zurück zum Zitat Winzer C, Wagner O, Festa A et al (2004) Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27:1721–1727CrossRefPubMed Winzer C, Wagner O, Festa A et al (2004) Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27:1721–1727CrossRefPubMed
25.
Zurück zum Zitat Di Benedetto A, Russo GT, Corrado F et al (2005) Inflammatory markers in women with a recent history of gestational diabetes mellitus. J Endocrinol Investig 28:34–38 Di Benedetto A, Russo GT, Corrado F et al (2005) Inflammatory markers in women with a recent history of gestational diabetes mellitus. J Endocrinol Investig 28:34–38
26.
Zurück zum Zitat Di Cianni G, Lencioni C, Volpe L et al (2007) C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 23:135–140CrossRefPubMed Di Cianni G, Lencioni C, Volpe L et al (2007) C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev 23:135–140CrossRefPubMed
27.
Zurück zum Zitat Catalano PM, Hoegh M, Minium J et al (2006) Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 49:1677–1685CrossRefPubMed Catalano PM, Hoegh M, Minium J et al (2006) Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 49:1677–1685CrossRefPubMed
28.
Zurück zum Zitat Kharroubi I, Rasschaert J, Eizirik DL, Cnop M (2003) Expression of adiponectin receptors in pancreatic beta cells. Biochem Biophys Res Commun 312:1118–1122CrossRefPubMed Kharroubi I, Rasschaert J, Eizirik DL, Cnop M (2003) Expression of adiponectin receptors in pancreatic beta cells. Biochem Biophys Res Commun 312:1118–1122CrossRefPubMed
29.
Zurück zum Zitat Staiger K, Stefan N, Staiger H et al (2005) Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta cell lipoapoptosis. J Clin Endocrinol Metab 90:6707–6713CrossRefPubMed Staiger K, Stefan N, Staiger H et al (2005) Adiponectin is functionally active in human islets but does not affect insulin secretory function or beta cell lipoapoptosis. J Clin Endocrinol Metab 90:6707–6713CrossRefPubMed
30.
Zurück zum Zitat Okamoto M, Ohara-Imaizumi M, Kubota N et al (2008) Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. Diabetologia 51:827–835CrossRefPubMed Okamoto M, Ohara-Imaizumi M, Kubota N et al (2008) Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. Diabetologia 51:827–835CrossRefPubMed
31.
Zurück zum Zitat Retnakaran R, Hanley AJ, Raif N et al (2005) Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 48:993–1001CrossRefPubMed Retnakaran R, Hanley AJ, Raif N et al (2005) Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 48:993–1001CrossRefPubMed
32.
Zurück zum Zitat Bacha F, Saad R, Gungor N, Arslanian SA (2004) Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta cell function. Diabetes Care 27:547–552CrossRefPubMed Bacha F, Saad R, Gungor N, Arslanian SA (2004) Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta cell function. Diabetes Care 27:547–552CrossRefPubMed
33.
Zurück zum Zitat Guldstrand M, Ahrén B, Adamson U (2004) Improved beta cell function after standardized weight reduction in severely obese subjects. Am J Physiol Endocrinol Metab 284:E557–E565 Guldstrand M, Ahrén B, Adamson U (2004) Improved beta cell function after standardized weight reduction in severely obese subjects. Am J Physiol Endocrinol Metab 284:E557–E565
34.
Zurück zum Zitat Musso G, Gambino R, Biroli G et al (2005) Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic beta cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol 100:2438–2446CrossRefPubMed Musso G, Gambino R, Biroli G et al (2005) Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic beta cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol 100:2438–2446CrossRefPubMed
35.
Zurück zum Zitat Koebnick C, Roberts CK, Shaibi GQ et al (2008) Adiponectin and leptin are independently associated with insulin sensitivity, but not with insulin secretion or beta cell function in overweight Hispanic adolescents. Horm Metab Res 40:708–712CrossRefPubMed Koebnick C, Roberts CK, Shaibi GQ et al (2008) Adiponectin and leptin are independently associated with insulin sensitivity, but not with insulin secretion or beta cell function in overweight Hispanic adolescents. Horm Metab Res 40:708–712CrossRefPubMed
36.
Zurück zum Zitat Clark HD, Graham ID, Karovitch A, Keely EJ (2009) Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial. Am J Obstet Gynecol 200(634):e1–e7 Clark HD, Graham ID, Karovitch A, Keely EJ (2009) Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial. Am J Obstet Gynecol 200(634):e1–e7
37.
Zurück zum Zitat Buchanan TA, Xiang AH, Peters RK et al (2002) Preservation of pancreatic beta cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796–2803CrossRefPubMed Buchanan TA, Xiang AH, Peters RK et al (2002) Preservation of pancreatic beta cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796–2803CrossRefPubMed
38.
Zurück zum Zitat Yu JG, Javorschi S, Hevener AL et al (2002) The effect of thiazolidinediones on plasma adiponectin levels in normal, obese and type 2 diabetic subjects. Diabetes 51:2968–2974CrossRefPubMed Yu JG, Javorschi S, Hevener AL et al (2002) The effect of thiazolidinediones on plasma adiponectin levels in normal, obese and type 2 diabetic subjects. Diabetes 51:2968–2974CrossRefPubMed
Metadaten
Titel
Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia
verfasst von
R. Retnakaran
Y. Qi
P. W. Connelly
M. Sermer
A. J. Hanley
B. Zinman
Publikationsdatum
01.02.2010
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 2/2010
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1600-8

Weitere Artikel der Ausgabe 2/2010

Diabetologia 2/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.